Eurofins Scientific【ERF】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

51.36

買値

50.80

売値

51.84

出来高

432,637

50.24 日の範囲 51.88

39.47 52 週間の範囲 62.10

時価総額

9.912B

前日終値

51.72

始値

51.74

時刻

51.36

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

392,028

発行済株式数

192,981,183

配当利回り

0.97%

PER

24.39

1 株当たり利益 (EPS)

2.11

歳入

6.97B

純利益

406.4M

セクター

Testing Laboratories

業界

Testing Laboratories

ウェブサイト

www.eurofins.com

本社

Grand Duche Du, Lux

設立

Eurofins Scientific SE is listed in the Testing Laboratories sector of the ユーロネクスト with ticker ERF. The last closing price for Eurofins Scientific was 51.72 €. Over the last year, Eurofins Scientific shares have traded in a share price range of 39.47 € to 62.10 €.

Eurofins Scientific currently has 192,981,183 shares in issue. The market capitalisation of Eurofins Scientific is 9.98 € billion. Eurofins Scientific has a price to earnings ratio (PE ratio) of 24.39.

CORRECTING and REPLACING: Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Regulatory News: This replaces the announcement made at 1:56 PM CEST on May 3 due to the following corrections: "Exercise of stock options and...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Regulatory News: Eurofins (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in...

Eurofins Core Business1 Delivers Strong Organic Revenue Growth in Q1 2022, in Line With Its Recently Upgraded Organic Growth2 Objective of 6.5% p.a.

Q1 2022 revenues of €1,760m, +9.1% vs. Q1 2021, despite a significant decrease in COVID related revenues Q1 2022 total revenue organic growth2...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2022

Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and...

EUROFINS SCIENTIFIC SE : AVIS DE CONVOCATION DES ACTIONNAIRES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE ET A L’ASSEMBLEE GENERALE EXTRAORDINAIRE DE LA SOCIETE VALANT AVIS D’INFORMATION DES OBLIGATAIRES

Regulatory News: EUROFINS SCIENTIFIC SE (Paris:ERF): Les actionnaires de la Société, et uniquement avec voix consultative les porteurs de...

Eurofins Genomics wird die Genotypisierung von bis zu 5 Millionen Teilnehmern an „Our Future Health“, dem bislang größten Gesundheitsforschungsprogramm des Vereinigten Königreichs, durchführen

Eurofins (Paris:ERF): Eurofins Genomics wird Our Future Health, das bislang größte Gesundheitsforschungsprogramm des Vereinigten Königreichs...

Eurofins Genomics réalisera le génotypage de 5 millions de participants au programme Our Future Health, le plus grand du genre pour la recherche en santé jamais mis en place au Royaume-Uni.

Eurofins (Paris : ERF) : Eurofins Genomics est fier d'annoncer son soutien à Our Future Health, le plus grand programme de recherche en santé...

Eurofins Genomics Will Be Conducting Genotyping for up to 5 Million Participants of Our Future Health, UK’s Largest Ever Health Research Programme

Eurofins (Paris:ERF): Eurofins Genomics is proud to announce its support for Our Future Health, the UK’s largest ever health research programme...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2022

Regulatory News: ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and...

Eurofins Significantly Exceeds Its Objectives in 2021 and Increases Its Objectives for 2022 and 2023

Regulatory News: Eurofins Scientific (Paris:ERF): Financial Highlights Eurofins delivered a very strong performance in FY 2021, exceeding all...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	3.46	7.22338204593	47.9	51.88	47.9	548569	49.75539607	DE
4	0.38	0.745390349157	50.98	51.88	47.89	400163	49.5911072	DE
12	3.24	6.73316708229	48.12	52.64	45.56	392028	49.16995757	DE
26	-1.38	-2.61660978385	52.74	58.24	44.7	393299	49.48803141	DE
52	-3.46	-6.31156512222	54.82	62.1	39.47	392837	51.26383998	DE
156	-34.65	-40.2860132543	86.01	100.5	39.47	389012	60.80284999	DE
260	-367.24	-87.7305303392	418.6	754	39.47	328962	77.64516802	DE

ERF - Frequently Asked Questions (FAQ)

What is the current Eurofins Scientific share price?

The current share price of Eurofins Scientific is 51.36 €

How many Eurofins Scientific shares are in issue?

Eurofins Scientific has 192,981,183 shares in issue

What is the market cap of Eurofins Scientific?

The market capitalisation of Eurofins Scientific is EUR 9.98B

What is the 1 year trading range for Eurofins Scientific share price?

Eurofins Scientific has traded in the range of 39.47 € to 62.10 € during the past year

What is the PE ratio of Eurofins Scientific?

The price to earnings ratio of Eurofins Scientific is 24.39

What is the cash to sales ratio of Eurofins Scientific?

The cash to sales ratio of Eurofins Scientific is 1.42

What is the reporting currency for Eurofins Scientific?

Eurofins Scientific reports financial results in EUR

What is the latest annual turnover for Eurofins Scientific?

The latest annual turnover of Eurofins Scientific is EUR 6.97B

What is the latest annual profit for Eurofins Scientific?

The latest annual profit of Eurofins Scientific is EUR 406.4M

What is the registered address of Eurofins Scientific?

The registered address for Eurofins Scientific is 23 VAL FLEURI, GRAND DUCHE DU, L-1526

What is the Eurofins Scientific website address?

The website address for Eurofins Scientific is www.eurofins.com

Which industry sector does Eurofins Scientific operate in?

Eurofins Scientific operates in the TESTING LABORATORIES sector

銘柄コード	株価	出来高
ALEUPEuroplasma	0.02 € (78.57%)	29.84M
MLAZRThe Azur Selection SA	1.13 € (61.43%)	47.07k
ALCYBCybergun	0.0003 € (50.00%)	290.89M
ALJXRArchos	0.241 € (37.71%)	524.29k
ALDOLDolfines	3.21 € (29.96%)	52.87k
DMSBSDiagnostic Medical Systems	0.0015 € (-81.25%)	14.15k
BNBSTonner Drones	0.002 € (-42.86%)	1.61M
TDBSTonner Drones	0.0038 € (-41.54%)	23.76M
BUIBarbara Bui	3.10 € (-24.39%)	1.05k
MLTROTroc de l Ile	2.50 € (-20.38%)	60
ALCYBCybergun	0.0003 € (50.00%)	290.89M
ATOAtos SE	0.0046 € (-6.12%)	201.87M
ALTDTonner Drones	0.027 € (-20.12%)	32.12M
ALEUPEuroplasma	0.02 € (78.57%)	29.84M
TDBSTonner Drones	0.0038 € (-41.54%)	23.76M

銘柄コード

株価

出来高

ALCYBCybergun

0.0003 €

(50.00%)

290.89M

ATOAtos SE

0.0046 €

(-6.12%)

201.87M

ALTDTonner Drones

0.027 €

(-20.12%)

32.12M

ALEUPEuroplasma

0.02 €

(78.57%)

29.84M

TDBSTonner Drones

0.0038 €

(-41.54%)

23.76M

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Eurofins Scientific SE (ERF)

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

Eurofins Scientific SE について

ERF 最新ニュース

CORRECTING and REPLACING: Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Eurofins Core Business1 Delivers Strong Organic Revenue Growth in Q1 2022, in Line With Its Recently Upgraded Organic Growth2 Objective of 6.5% p.a.

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2022

EUROFINS SCIENTIFIC SE : AVIS DE CONVOCATION DES ACTIONNAIRES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE ET A L’ASSEMBLEE GENERALE EXTRAORDINAIRE DE LA SOCIETE VALANT AVIS D’INFORMATION DES OBLIGATAIRES

Eurofins Genomics wird die Genotypisierung von bis zu 5 Millionen Teilnehmern an „Our Future Health“, dem bislang größten Gesundheitsforschungsprogramm des Vereinigten Königreichs, durchführen

Eurofins Genomics réalisera le génotypage de 5 millions de participants au programme Our Future Health, le plus grand du genre pour la recherche en santé jamais mis en place au Royaume-Uni.

Eurofins Genomics Will Be Conducting Genotyping for up to 5 Million Participants of Our Future Health, UK’s Largest Ever Health Research Programme

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2022

Eurofins Significantly Exceeds Its Objectives in 2021 and Increases Its Objectives for 2022 and 2023

ERF - Frequently Asked Questions (FAQ)

ムーバー

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Eurofins Scientific SE (ERF) 銘柄情報

Eurofins Scientific SE (ERF)

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

Eurofins Scientific SE について

ERF 最新ニュース

CORRECTING and REPLACING: Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Eurofins Core Business1 Delivers Strong Organic Revenue Growth in Q1 2022, in Line With Its Recently Upgraded Organic Growth2 Objective of 6.5% p.a.

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2022

EUROFINS SCIENTIFIC SE : AVIS DE CONVOCATION DES ACTIONNAIRES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE ET A L’ASSEMBLEE GENERALE EXTRAORDINAIRE DE LA SOCIETE VALANT AVIS D’INFORMATION DES OBLIGATAIRES

Eurofins Genomics wird die Genotypisierung von bis zu 5 Millionen Teilnehmern an „Our Future Health“, dem bislang größten Gesundheitsforschungsprogramm des Vereinigten Königreichs, durchführen

Eurofins Genomics réalisera le génotypage de 5 millions de participants au programme Our Future Health, le plus grand du genre pour la recherche en santé jamais mis en place au Royaume-Uni.

Eurofins Genomics Will Be Conducting Genotyping for up to 5 Million Participants of Our Future Health, UK’s Largest Ever Health Research Programme

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2022

Eurofins Significantly Exceeds Its Objectives in 2021 and Increases Its Objectives for 2022 and 2023

ERF - Frequently Asked Questions (FAQ)

ムーバー

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

広告を削除する